Biomedical subjects

Andreas Reitner

Publications and source records attributed to Andreas Reitner.

5 recordsLinked to original sources

PubMed2005

[Neuroophthalmology: milestones and new trends].

The 100 years anniversary of the "Ophthalmologische Gesellschaft in Wien" raises the interesting question how neuroophthalmology was represented in the decades before and after this historic event. At the beginning of the 19th century almost all diseases "behind" the pupil were diagnosed as "schwarzer Star". Despite of describing the different symptoms precisely the colleagues could only argue the underlying aetiology. About 100 years later the giants of "old" neuroophthalmology had described almost all diseases and anatomical concepts.

Austria↗

PubMed2003

Glare and halo phenomena after laser in situ keratomileusis.

PURPOSE: To simulate and measure subjectively observed glare and halos after laser in situ keratomileusis (LASIK). SETTING: University of Vienna, Medical School, Department of Ophthalmology, Vienna, Austria. METHODS: In 16 eyes of 10 patients, the best corrected visual acuity (BCVA) and subjectively observed glare and halo size under mesopic conditions were measured before LASIK and 1, 3, and 6 months postoperatively. Infrared pupillography was used to ensure that all patients had a larger ablation zone than the measured pupil size under mesopic conditions. RESULTS: Preoperatively, the mean Snellen BCVA was 0.88 +/- 0.17 (SD) and the mean glare and halo size was 1.97 +/- 1.20 square degrees (sqd) before the treatment. One month after LASIK, the BCVA was 0.83 +/- 0.29 and the mean glare and halo size, 2.61 +/- 3.14 sqd. Three months after LASIK, the mean values were 0.90 +/- 0.26 and 1.88 +/- 2.37 sqd, respectively. Six months after LASIK treatment, they were 0.85 +/- 0.28 and 1.30 +/- 1.63 sqd, respectively. The 95% confidence interval for the difference between preoperative glare and halo and glare and halo at 6 months was -1.56 to + 0.51 sqd. CONCLUSIONS: Subjectively observed glare and halo size after LASIK reached a peak after 1 month and decreased in the following postoperative period.

Adult↗

PubMed2002

[Functional assessment before and after interventions on the optic chiasm system].

OBJECTIVES: In the course of a tumor in the area of the optic chiasm the optochiasmal system is often exposed to compressive and vascular irritations. This study deals with the functional results (visual acuity and visual field) before and after surgery based on the primary situation and morphology of the tumor in order to give a prognosis on this matter. METHODS: 62 patients (41 female, 21 male) suffering from tumors in the area of the optic chiasm were retrospectively reviewed. The duration of the follow-up was an average of 25.82 months, +/- 20.04. Among the tumors investigated there were 36 pituitary adenomas, 20 meningiomas, 4 craniopharyngiomas, one histiozytosis X and one gangliozytoma. For visual field examination the Humphrey Field Analyzer, program 30-2, was used. 34 tumors (54.8%) were excised by the transsphenoidal approach, 28 patients (45.2%) underwent transcranial surgery. RESULTS: As for visual acuity, of the 124 eyes 53 eyes (42.8%) improved after surgery, 64 eyes (51.6%) remained unchanged, 7 eyes (5.6%) deteriorated. Of the patients who underwent transsphenoidal surgery, 28 eyes (41.2%) improved after operation, 36 eyes (52.9%) remained unchanged, and 4 eyes (5.9%) worsened. In case of transcranial surgery, 25 eyes (44.6%) improved, 28 eyes (50.0%) remained unchanged, whereas 3 eyes (5.4%) worsened. There was a postoperative improvement in 53.2% of the visual fields, 37.1% remained unchanged, whereas 9.7% deteriorated. CONCLUSION: Both the transsphenoidal and transcranial approaches showed excellent visual outcome. Our experience indicates an excellent prognosis for improvement of visual acuity and visual fields provided an adequate procedure. Results depend, however, on the primary functional and morphological situation. In the case of a large supra-/parasellar tumor component a postoperative deterioration of vision may occur.

Adenoma↗

PubMed2002

Chlamydia pneumoniae in central retinal artery occlusion.

PURPOSE: There is increasing evidence that the common respiratory human pathogen Chlamydia pneumoniae has a causative role in atherosclerosis. We investigated the association of this pathogen with acute central retinal artery occlusion (CRAO). PATIENTS AND METHODS: Sera of 14 consecutive patients with CRAO and of 14 age- and sex-matched control subjects were examined. Antibodies against chlamydial lipopolysaccharide (LPS) and outer membrane proteins of C. pneumoniae were determined by an enzyme-linked immunosorbent assay (ELISA). RESULTS: In the CRAO group, seven patients (50%) were found to be IgA positive, 12 (86%) were IgG positive and one (7%) was IgM positive for chlamydial LPS antibodies. In the control group 36%, 79% and 14% were IgA, IgG and IgM positive, respectively. The results showed no significant difference between the groups. In the CRAO group, IgA, IgG and IgM antibodies to C. pneumoniae were found in 43%, 79% and 0% of subjects, respectively. These findings did not differ significantly from those pertaining to matched controls. CONCLUSIONS: These data do not support an association between acute CRAO and current C. pneumoniae infection.

Acute Disease↗

PubMedDate not supplied

Chlamydia in anterior ischemic optic neuropathy.

There is an increasing body of evidence linking the common respiratory human pathogen Chlamydia pneumoniae with atherosclerosis and other vascular disorders. Our research was designed to investigate the association of this organism with anterior ischemic optic neuropathy (AION), representing an acute ischemic disorder of the optic nerve head. Sera were examined of 14 consecutive patients with AION and of 14 age- and sex-matched control subjects with noncardiovascular, nonpulmonary disorders. Antibodies against chlamydial lipopolysaccharide (LPS) and outer membrane proteins of C. pneumoniae were determined by ELISA. Further, nucleic acid amplification tests were done in order to detect C. pneumoniae-specific nucleotide sequences. Four patients (29%) were IgA positive, 11 (79%) were IgG positive and 1 (7%) was IgM positive for chlamydial LPS antibodies. In the control group, 36, 79 and 7% were IgA, IgG and IgM positive and showed no significant difference. IgA, IgG and IgM antibodies to C. pneumoniae were found in 43, 79 and 0% and did not differ from matched controls. By the nucleic acid amplification test, specific C. pneumo niae sequences were neither detected in the AION patients nor in the control group. These data do not support the association of AION with previous C. pneumoniae infection. However, it remains unclear whether Chlamydia actually initiates atherosclerotic injury, facilitates its progression or plays another role in other vascular disorders.

Acute Disease↗